CAR-T Companies

Global database of 168 CAR-T cell therapy companies through 15 January 2019. This database includes all companies worldwide with CAR-T cell therapeutic assets or programs (wholly owned, licensed or co-developed) in any stage of development (from preclinical to commercial). It does not contain information about vendors to CAR-T companies (manufacturers of reagents, materials, and devices) or service providers.

For each company:

  • Company name
  • Link to company website if available
  • Country of origin
  • Phase of development (preclinical or clinical)
  • Type of cell products
  • Key partner or licensee/licensor

Updates from Aug 2018 to Jan 2019:

  • 19 companies added
  • 1 company removed (Novartis acquired Endocyte)
  • 6 key partners/ licensee-licensor updates
  • 3 phase of development updates

Original file posted Aug 2018: 150 companies (63 in China and 87 in other countries).

Public samples:
Sample-CAR-T-companies.xlsx10.04 KB